Statera Biopharma, Inc.
STABDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001318641
Statera Biopharma, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Oct 28, 2021; 29 institutions reported holding it in 13F filings for Q4 2022, worth $197.5K in total; no superinvestor held it.
13F holders, Q1 2021
Institutional positions in Statera Biopharma, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- No complete 13F data for Q4 2020
- Shares held
- 1.07M
- No complete 13F data for Q4 2020
- Total value
- $5.61M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting STAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $1 |
| Q1 2024 | 1 | $1 |
| Q4 2023 | 1 | $1 |
| Q3 2023 | 1 | $0 |
| Q2 2023 | 1 | $30 |
| Q1 2023 | 4 | $3.29K |
| Q4 2022 | 29 | $197.5K |
| Q3 2022 | 35 | $383.3K |
| Q2 2022 | 35 | $894.9K |
| Q1 2022 | 33 | $669.2K |
| Q4 2021 | 29 | $4.64M |
| Q3 2021 | 23 | $2.81M |
| Q2 2021 | 21 | $4.31M |
| Q1 2021 | 22 | $5.61M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Statera Biopharma, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sabby Management, LLC | 478,941 | $2.51M | 1.85% | – | – |
| Morgan Stanley | 217,290 | $1.14M | 0.00% | – | – |
| Renaissance Technologies LLC | 130,551 | $685.0K | 0.00% | – | – |
| Vanguard Group Inc | 68,092 | $357.0K | 0.00% | – | – |
| Geode Capital Management, LLC | 44,474 | $233.0K | 0.00% | – | – |
| ARS Investment Partners, LLC | 36,981 | $194.0K | 0.02% | – | – |
| Citadel Advisors LLC | 36,626 | $192.0K | 0.00% | – | – |
| Cambridge Investment Research Advisors, Inc. | 36,025 | $189.0K | 0.00% | – | – |
| Northern Trust Corp | 11,538 | $61.0K | 0.00% | – | – |
| Royal Bank of Canada | 3,620 | $19.0K | 0.00% | – | – |
| US Bancorp | 1,000 | $5.00K | 0.00% | – | – |
| Bank of America Corp | 637 | $4.00K | 0.00% | – | – |
| BlackRock Inc. | 741 | $4.00K | 0.00% | – | – |
| CWM, LLC | 438 | $2.00K | 0.00% | – | – |
| Archer Investment Corp | 300 | $1.57K | 0.00% | – | – |
| Northwestern Mutual Wealth Management Co | 125 | $1.00K | 0.00% | – | – |
| IFP Advisors, Inc | 150 | $1.00K | 0.00% | – | – |
| Advisor Group Holdings, Inc. | 290 | $1.00K | 0.00% | – | – |
| FourThought Financial, LLC | 125 | $1.00K | 0.00% | – | – |
| Wells Fargo & Company | 51 | $0 | 0.00% | – | – |
| Bank of Montreal | 31 | $0 | 0.00% | – | – |
| Orion Capital Management LLC | 50 | $0 | 0.00% | – | – |